JPRN-UMIN000018441Completed未知
A single-arm study on the effectiveness of nutritional supplements containing amino acids for chemotherapy-induced mucositis. - A study of supplements containing amino acids for mucositis.
Kyoto Prefectural University of Medicine0 sites30 target enrollmentStarted: September 1, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who reject to participate in this trial, or who are in condition of being unable to make conscious judgment.
Investigators
Similar Trials
Recruiting
Not Applicable
A Study for evaluating the effectiveness of nutrition therapy in patients with cirrhosis with impaired glucose tolerance using continuous glucose monitoring and body composition analyzerCirrhosis with impaired glucose toleranceJPRN-UMIN000035952Hamamatsu University School of Medicine250
Recruiting
Not Applicable
Assess the effectiveness of nutritional improvement programme towards improving the knowledge and micronutrient deficiency assessment skills of mothers of anganwadi children and dietary intake of micronutrients of anganwadi children in selected anganwadi centres of Udupi district, Karnataka.CTRI/2018/02/011655nil
Not yet recruiting
Phase 2
A trial to evidence based evaluation of the benefits of Nutri Bar a Multi Herbal Formulation, in Pandu Roga or IRON DEFICIENCY ANEMIA.CTRI/2017/12/010979CSIR Palampur
Active, not recruiting
Phase 1
A single-arm study to demonstrate the efficacy and safety of Privigen in the treatment of subjects with chronic inflammatory demyelinating polyneuropathy (CIDP)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 13.1Level: PTClassification code 10061811Term: Demyelinating polyneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-017672-24-BECSL Behring GmbH30
Active, not recruiting
Not Applicable
This research study will investigate whether the investigational medicine IgPro10 is efficient and safe for patients with chronic inflammatory demyelinating polyneuropathy (CIDP).Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 14.0Level: PTClassification code 10061811Term: Demyelinating polyneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-017672-24-FICSL Behring GmbH30